BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20128974)

  • 1. [Status of hepatitis C in Guangzhou from 2005 to 2008].
    Lin CS; Zhao ZX; Zhang XH; Guo XY; Li TG; Chong YT; Gao ZL
    Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):63-4. PubMed ID: 20128974
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk of HBV liver disease in isolated antiHbc patients receiving immuno-chemotherapy for non Hodgkin lymphoma.
    Targhetta C; Cabras MG; Angelucci E
    Haematologica; 2008 Nov; 93(11):e66. PubMed ID: 18978292
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiologic and therapeutic status study of patients with hepatitis C].
    Xu M; Shi HY; Cai WP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):135-6. PubMed ID: 21863640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care-associated transmission of hepatitis B and C viruses in hemodialysis units.
    Fabrizi F; Martin P
    Clin Liver Dis; 2010 Feb; 14(1):49-60; viii. PubMed ID: 20123439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High prevalence of risk behaviour concurrent with links to other high-risk populations: a potentially explosive HIV epidemic among men who have sex with men in Guangzhou, China.
    He Q; Wang Y; Lin P; Raymond HF; Li Y; Yang F; Zhao J; Li J; Ling L; McFarland W
    Sex Transm Infect; 2009 Sep; 85(5):383-90. PubMed ID: 19357129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis, Diagnosis and Therapy of Hepatitis-B-Virus-(HBV-)Infection: upgrade of the guideline, AWMF-Register 021/011].
    Cornberg M; Protzer U; Dollinger MM; Petersen J; Wedemeyer H; Berg T; Jilg W; Erhardt A; Wirth S; Schirmacher P; Fleig WE; Manns MP
    Z Gastroenterol; 2007 Jun; 45(6):525-74. PubMed ID: 17554641
    [No Abstract]   [Full Text] [Related]  

  • 7. Prevalence and mode of spread of hepatitis B and C in rural Sindh, Pakistan.
    Abbas Z; Jeswani NL; Kakepoto GN; Islam M; Mehdi K; Jafri W
    Trop Gastroenterol; 2008; 29(4):210-6. PubMed ID: 19323090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of hepatitis B and C in Egypt and Africa.
    Attia MA
    Antivir Ther; 1998; 3(Suppl 3):1-9. PubMed ID: 10726051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatitis B and hepatitis C, a high stake for public health: how to reconcile health cost control and public health expenses?].
    Allerg Immunol (Paris); 1997 Sep; 29(7):215-8. PubMed ID: 9432191
    [No Abstract]   [Full Text] [Related]  

  • 10. [Epidemiological study of hepatitis B and C in 34,336 patients operated at Hiroshima Prefectural Hospital during the period from 1993 to 2000].
    Taguchi S; Nishioka K; Kawaguchi R; Nakao M; Watanabe I; Migita T
    Masui; 2004 Jun; 53(6):696-700. PubMed ID: 15242049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of hepatitis B, C, and delta virus infections among children in Mongolia: progress in childhood immunization.
    Tsatsralt-Od B; Takahashi M; Endo K; Agiimaa D; Buyankhuu O; Ninomiya M; Lorenzo FR; Okamoto H
    J Med Virol; 2007 Aug; 79(8):1064-74. PubMed ID: 17596839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HVB and HVC infections in nephrology].
    Pol S
    Nephrologie; 2001; 22(6):321-2. PubMed ID: 11715611
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
    Meffre C; Le Strat Y; Delarocque-Astagneau E; Dubois F; Antona D; Lemasson JM; Warszawski J; Steinmetz J; Coste D; Meyer JF; Leiser S; Giordanella JP; Gueguen R; Desenclos JC
    J Med Virol; 2010 Apr; 82(4):546-55. PubMed ID: 20166185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of viral hepatitis prevention among underprivileged people in the Lyon area of France.
    Sahajian F; Bailly F; Vanhems P; Fantino B; Vannier-Nitenberg C; Fabry J; Trepo C;
    J Public Health (Oxf); 2011 Jun; 33(2):182-92. PubMed ID: 20876189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatitis B and C risk factors in Germany--results of the national surveillance].
    Walter J; Radun D; Claus H; Hamouda O; Stark K
    Gesundheitswesen; 2005 Jul; 67(7):441-7. PubMed ID: 16103966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prevalence of risk factors and mechanisms of transmission of acute viral hepatitis type B and C in Bucharest municipality: 2001-2008].
    Ion-Nedelcu N; Iordăchescu C; Gherasim P; Mihailovici R; Dragomirescu C; Dumitrache-Marian R; Moculescu C
    Bacteriol Virusol Parazitol Epidemiol; 2009; 54(2):103-8. PubMed ID: 20422924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study on the status of HBV infection and influencing factors in a population aged 1 to 59 years old in Tianjin].
    Li YC; Zhu XJ; Zhang ZL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2009 Jun; 30(6):652. PubMed ID: 19957644
    [No Abstract]   [Full Text] [Related]  

  • 18. The seroprevalence of hepatitis A and B in people testing positive for hepatitis C.
    Kiefer LA; Honish A; Predy G; Talbot JA
    CMAJ; 2000 Jan; 162(2):207-8. PubMed ID: 10674054
    [No Abstract]   [Full Text] [Related]  

  • 19. [Prevalence of hepatitis A, B, C virus markers in Réunion (south hospital and Saint Pierre prison)].
    Michault A; Faulques B; Sevadjan B; Troalen D; Marais A; Barau G
    Bull Soc Pathol Exot; 2000 Feb; 93(1):34-40. PubMed ID: 10774493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Epidemiological aspects of viral hepatitis: immunogenicity of hepatitis B vaccine administered to children and adolescents].
    del Rey Calero J
    An R Acad Nac Med (Madr); 1992; 109(2):261-96; discussion 296-8. PubMed ID: 1463144
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.